Patents by Inventor Alexander Mark Schobel

Alexander Mark Schobel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DELIVERY PHARMACEUTICAL COMPOSITIONS INCLUDING PERMEATION ENHANCERS
    Publication number: 20190091281
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: September 26, 2018
    Publication date: March 28, 2019
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Stephen Paul Wargacki, Rajesh Kumar Kainthan, Alexander Mark Schobel
  • PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
    Publication number: 20190022022
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 24, 2019
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS
    Publication number: 20190022023
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 24, 2019
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
    Publication number: 20180200198
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: October 3, 2017
    Publication date: July 19, 2018
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
    Publication number: 20180125977
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: September 27, 2017
    Publication date: May 10, 2018
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
    Publication number: 20180104195
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: October 23, 2017
    Publication date: April 19, 2018
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
    Publication number: 20170348251
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: May 4, 2017
    Publication date: December 7, 2017
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
    Publication number: 20170290776
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: May 4, 2017
    Publication date: October 12, 2017
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • FILM DELIVERY SYSTEM FOR ACTIVE INGREDIENTS
    Publication number: 20170042830
    Abstract: The present invention includes a pharmaceutical-based film system which includes various small-scale forms of pharmaceutically active agents, including testosterone esters, in a film base. Such forms include nanoparticles, microparticles, and combinations thereof. Methods of producing such film and providing a dosage of the pharmaceutical in a film are also provided.
    Type: Application
    Filed: May 17, 2016
    Publication date: February 16, 2017
    Inventors: Garry L. Myers, Eric Dadey, Alexander Mark Schobel
  • Combination peptide-nanoparticles and delivery systems incorporating same
    Patent number: 9474687
    Abstract: Nanoparticles having a core and a corona of ligands covalently linked to the core, wherein differing species of peptides are bound to the nanoparticles and incorporated into various dosage forms.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: October 25, 2016
    Assignees: MONOSOL RX, LLC, MIDATECH LIMITED
    Inventors: Phillip Williams, Thomas Rademacher, Alexander Mark Schobel, Eric Dadey
  • COMBINATION PEPTIDE-NANOPARTICLES AND DELIVERY SYSTEMS INCORPORATING SAME
    Publication number: 20150099698
    Abstract: Nanoparticles having a core and a corona of ligands covalently linked to the core, wherein differing species of peptides are bound to the nanoparticles and incorporated into various dosage forms.
    Type: Application
    Filed: October 8, 2013
    Publication date: April 9, 2015
    Inventors: Phillip Williams, Thomas Rademacher, Alexander Mark Schobel, Eric Dadey
  • Use of dams to improve yield in film processing
    Patent number: 8956685
    Abstract: The present invention relates to methods for forming films. In particular, the present invention relates to the formation of films on a substrate, the substrate having at least one dam portion.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: February 17, 2015
    Assignee: Monosol RX, LLC
    Inventors: Beuford A. Bogue, Alexander Mark Schobel, Keith J. Kendall
  • Orally disintegrating pharmaceutical composition comprising diclofenac
    Patent number: 8911769
    Abstract: The invention relates to pharmaceutical compositions suitable for oral administration in the form of edible films comprising diclofenac.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: December 16, 2014
    Assignee: Novartis AG
    Inventors: Gavin Murray Spencer, Alexander Mark Schobel, Greg Slominski, Stephan Meyer, Isabelle Rault
  • FILMS AND DRUG DELIVERY SYSTEMS FOR RIZATRIPTAN
    Publication number: 20140275194
    Abstract: The invention relates to film products including a polymer component and a therapeutically effective amount of rizatriptan or a pharmaceutically acceptable salt thereof. The invention further relates to film products including a polymer component and a therapeutically effective amount of rizatriptan benzoate.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventors: Eric Dadey, Alexander Mark Schobel, Daniel R. Barber, Garry L. Myers
  • STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
    Publication number: 20140255473
    Abstract: The present invention is directed to steroid hormone delivery systems and methods of preparing the same. In particular, the steroid hormone delivery systems provided include a primary construct having one or more hydrophobic steroid hormone esters in the form of a liposome, a lipid particle, a micelle, an emulsion or a niosome which is then formulated into a secondary construct for administration. Exemplary secondary constructs include a film for sublingual or buccal administration.
    Type: Application
    Filed: May 19, 2014
    Publication date: September 11, 2014
    Applicant: MONOSOL RX, LLC
    Inventors: Eric Dadey, Alexander Mark Schobel
  • Combination peptide-nanoparticles and delivery systems incorporating same
    Patent number: 8790704
    Abstract: Nanoparticles having a core and a corona of ligands covalently linked to the core, wherein differing species of peptides are bound to the nanoparticles and incorporated into various dosage forms.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: July 29, 2014
    Assignees: Monosol RX, LLC, Midatech Limited
    Inventors: Phillip Williams, Thomas Rademacher, Alexander Mark Schobel, Eric Dadey
  • ANTI-PAIN AND ANTI-NAUSEA AND/OR VOMITING COMBINATORIAL COMPOSITIONS
    Publication number: 20140073678
    Abstract: In one aspect, the present invention discloses combinational compositions for treating users experiencing symptoms associated with a migraine or other central nervous system related pain disorder that can cause or exacerbate nausea and/or vomiting or other central nervous system related pain disorder that can cause or exacerbate nausea and/or vomiting. The combinational composition includes a first pharmaceutical active component for treating pain, and a second pharmaceutical active component for treating nausea and/or vomiting and/or vomiting in a user.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 13, 2014
    Applicant: MONOSOL RX, LLC
    Inventors: Eric Dadey, Alexander Mark Schobel, Daniel R. Barber, Garry L. Myers
  • Dietary fiber composition
    Patent number: 8568767
    Abstract: The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable without the need of an ingestion aid.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: October 29, 2013
    Assignee: Novartis AG
    Inventors: Nils William Ahlgren, Ronald Lee Dahl, Monte Lee Friesen, Alexander Mark Schobel
  • STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
    Publication number: 20130045271
    Abstract: The present invention is directed to steroid hormone delivery systems and methods of preparing the same. In particular, the steroid hormone delivery systems provided include a primary construct having one or more hydrophobic steroid hormone esters in the form of a liposome, a lipid particle, a micelle, an emulsion or a niosome which is then formulated into a secondary construct for administration. Exemplary secondary constructs include a film for sublingual or buccal administration.
    Type: Application
    Filed: August 17, 2012
    Publication date: February 21, 2013
    Applicant: MonoSol Rx, LLC
    Inventors: Eric Dadey, Alexander Mark Schobel
  • Dietary fiber composition
    Patent number: 8372426
    Abstract: The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable without the need of an ingestion aid.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: February 12, 2013
    Assignee: Novartis Consumer Health S.A.
    Inventors: Nils William Ahlgren, Ronald Lee Dahl, Monte Lee Friesen, Alexander Mark Schobel